Repeated mechanical thrombectomy for recurrent large vessel occlusion: A systematic review and meta-analysis

医学 改良兰金量表 冲程(发动机) 荟萃分析 观察研究 闭塞 内科学 外科 缺血性中风 缺血 机械工程 工程类
作者
Mohamed Elfil,Eshak I. Bahbah,Ahmed Bayoumi,Mohammad Aladawi,Mohamed Eldokmak,Mohamed M. Salem,Pakinam E Aboutaleb,Brian Villafuerte-Trisolini,Fawaz Al‐Mufti,Santiago Ortega‐Gutiérrez,Marco Gonzalez‐Castellon
出处
期刊:Interventional Neuroradiology [SAGE Publishing]
卷期号:: 159101992211343-159101992211343 被引量:7
标识
DOI:10.1177/15910199221134307
摘要

Background Mechanical thrombectomy (MT) is the standard treatment for acute large vessel occlusion (LVO). Recurrent LVO can still occur in patients who already underwent MT for the first LVO. This study aimed to evaluate the efficacy of repeating MT for recurrent LVO. Methods This meta-analysis of the available literature was conducted to summarize the current evidence regarding repeated MT outcomes in patients with recurrent LVO. All studies with ≥ 1 outcomes of interest were included. The Newcastle-Ottawa Scale (NOS) was used for risk of bias assessment. Results Twenty studies, 10 observational (n = 21,251 patients) and 10 case reports (n = 10 patients), were included. 266 patients (62.78% females) with recurrent LVO were identified, with an overall prevalence of 1.6% and a mean age of 65.67 ± 16.23 years. Cardio-embolism was the most common mechanism in both times, with a median of 15 days between the first and second LVOs. Compared with pre-intervention, the first and second MTs significantly reduced the National Institute of Health Stroke Scale (NIHSS) score, (mean difference (MD) = −8.91) and (MD = −5.97) respectively, with a significant difference (p = 0.001). The rate of favorable outcome (modified Rankin scale (mRS) score 0–3) was 82.6% and 59.2% after the first and second MTs respectively, with a significant difference (p < 0.001). Conclusion In properly selected recurrent LVO patients, repeated MT is efficacious and safe. A prior MT procedure should not discourage aggressive treatment as many patients may achieve favorable outcomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
华仔应助科研通管家采纳,获得10
刚刚
顾矜应助科研通管家采纳,获得30
刚刚
完美世界应助科研通管家采纳,获得10
刚刚
小青椒应助科研通管家采纳,获得30
刚刚
我是老大应助科研通管家采纳,获得10
刚刚
ss完成签到,获得积分10
1秒前
OCDer完成签到,获得积分0
1秒前
3秒前
3秒前
KongHN完成签到,获得积分10
4秒前
lucky完成签到 ,获得积分10
6秒前
hotdx完成签到,获得积分10
6秒前
OCDer发布了新的文献求助100
6秒前
金色稻谷完成签到,获得积分10
7秒前
山谷发布了新的文献求助10
8秒前
枝头树上的布谷鸟完成签到 ,获得积分10
9秒前
俏皮诺言完成签到,获得积分10
12秒前
17秒前
呆萌的鼠标完成签到 ,获得积分0
18秒前
是是是WQ完成签到 ,获得积分0
18秒前
21秒前
自由的大叔完成签到 ,获得积分10
22秒前
曦玥完成签到,获得积分10
23秒前
搞怪薯片发布了新的文献求助10
24秒前
sam完成签到 ,获得积分10
25秒前
lrll发布了新的文献求助10
26秒前
科科克尔克完成签到 ,获得积分10
31秒前
LEE佳完成签到 ,获得积分10
32秒前
一行白鹭上青天完成签到 ,获得积分10
33秒前
lrll完成签到,获得积分10
34秒前
我是老大应助糊涂的友安采纳,获得10
35秒前
36秒前
Yang22完成签到,获得积分10
43秒前
扶石完成签到,获得积分10
45秒前
Alma发布了新的文献求助10
48秒前
可口可乐完成签到,获得积分10
49秒前
乐观健柏完成签到,获得积分10
52秒前
Beyond095完成签到 ,获得积分10
52秒前
54秒前
怡然猎豹完成签到,获得积分0
54秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
求中国石油大学(北京)图书馆的硕士论文,作者董晨,十年前搞太赫兹的 500
Vertebrate Palaeontology, 5th Edition 500
Narrative Method and Narrative form in Masaccio's Tribute Money 500
Aircraft Engine Design, Third Edition 500
Neonatal and Pediatric ECMO Simulation Scenarios 500
苏州地下水中新污染物及其转化产物的非靶向筛查 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 4774578
求助须知:如何正确求助?哪些是违规求助? 4107399
关于积分的说明 12705026
捐赠科研通 3828356
什么是DOI,文献DOI怎么找? 2111991
邀请新用户注册赠送积分活动 1135988
关于科研通互助平台的介绍 1019478